Authors
Loading...
Multicenter study finds high infection rates in NHL patients receiving B-cell depleting immunotherapies, indicating severe immunocompetence challenges.
Castellino et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: